Voriconazole: a new triazole antifungal (Q33917339)

30 July 2017

title

Voriconazole: a new triazole antifungal (English)

1 reference

30 July 2017

1 reference

J A Sabo

1

1 reference

30 July 2017

S M Abdel-Rahman

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

Annals of Pharmacotherapy

30 July 2017

published in

1 reference

30 July 2017

volume

34

1 reference

30 July 2017

issue

9

1 reference

30 July 2017

page(s)

1032-1043

1 reference

Renal effects of amphotericin B lipid complex.

30 July 2017

cites work

1 reference

Antifungal agents in the 1990s. Current status and future developments

21 January 2018

1 reference

Clinical pharmacokinetics of fluconazole

21 January 2018

1 reference

Pharmacokinetic optimisation of oral antifungal therapy

21 January 2018

1 reference

Comparison of the modified Stokes' method of susceptibility testing with results obtained using MIC methods and British Society of Antimicrobial Chemotherapy breakpoints.

21 January 2018

1 reference

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

21 January 2018

1 reference

In vitro susceptibility of dermatophytes to antifungal drugs: a comparison of two methods.

21 January 2018

1 reference

Pharmacokinetics of newer drugs in patients with renal impairment (Part I).

21 January 2018

1 reference

Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.

21 January 2018

1 reference

Optimisation of itraconazole therapy using target drug concentrations.

21 January 2018

1 reference

Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses

21 January 2018

1 reference

Itraconazole and fluconazole: new drugs for deep fungal infection

21 January 2018

1 reference

The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects.

21 January 2018

1 reference

Pharmacokinetics of itraconazole following oral administration to normal volunteers

21 January 2018

1 reference

Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B.

21 January 2018

1 reference

The effect of the new triazole, voriconazole (UK-109,496), on the interactions of Candida albicans and Candida krusei with endothelial cells.

21 January 2018

1 reference

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients

21 January 2018

1 reference

A comparative review of colony-stimulating factors

21 January 2018

1 reference

Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus

21 January 2018

1 reference

Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia.

21 January 2018

1 reference

Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease.

21 January 2018

1 reference

The search for new triazole antifungal agents

21 January 2018

1 reference

The future of antifungal therapy

21 January 2018

1 reference

Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery

21 January 2018

1 reference

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

21 January 2018

1 reference

Therapeutic outcome in invasive aspergillosis

21 January 2018

1 reference

An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis.

21 January 2018

1 reference

Lymphocutaneous infection due to Scedosporium apiospermum

21 January 2018

1 reference

Clinical resolution of Scedosporium prolificans fungemia associated with reversal of neutropenia following administration of granulocyte colony-stimulating factor

21 January 2018

1 reference

Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group.

21 January 2018

1 reference

Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata

21 January 2018

1 reference

Fluconazole resistance in Candida glabrata

21 January 2018

1 reference

Resistance of Candida albicans to azole antifungal agents

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.19237

1 reference

30 July 2017

1 reference